In 1979, Matthew Autterson graduated Michigan State University with a bachelor’s degree in finance. In 1981, he furthered his studies at the University of Denver and completed the Universities Graduate Tax program. The program is the largest and one of the oldest tax programs in the United States. Upon completing his tax course, Matthew joined First Trust Corporation in 1980, which at the time was a subsidiary of Fiserv Corporation. After several years of gaining valuable experience, knowledge and contacts he and several associates started their own financial services company called Resources Trust Company (RTC), which was to be a subsidiary of Integrated Resources, Inc.
Integrated Resources, Inc. was a financial services company based in New York until it was acquired by SunAmerica. In 1986, Matthew Autterson was elected as President of RTC due to his excellent leadership and managerial skills. For the next 13 years Matthew would work hard at growing RTC into a successful financial services company that was so unique that in 1998, AIG offered $18 billion to acquire 100% of RTC Inc. In 2001, just three years later, AIG’s RTC subsidiary grew to be the largest FDIC-insured trust company in the United States. In 2001, Fiserv acquired RTC and would manage over $32 billion in assets making it one of the largest financial services companies in the world at the time.
However, Matthew Autterson’s philosophy was always to help others. During his immaculate career he would contribute to various charities and support non-profit organization such as, the Denver Zoo, Webb-Waring and the Denver Zoological Foundation, but Matthew always wanted to do more.
In 2013, Matthew joined Scott Falci’s newest non-profit organization, Falci Adaptive Biosystems. The organization helps individuals suffering from neuro-motor disabilities and attempts to make their lives more functional and manageable. Matthew was asked to be on the board of directors for Falci Adaptive Biosystems and also became the President and CEO of CNS Biosciences. CNS Biosystems is directly related to Falci Adaptive Biosystems, but researches and develops clinical stage medicines to eliminate neuropathic pain as well. See This Page for more information
CNS Biosciences is a non-profit organization and is supported by many individuals including its present CEO Matthew who will do everything in his power to accomplish CNS’s goals. Matthew has achieved so much in his career and continues to surpass his personal and philanthropic goals and commitments. He is truly a role model for the world.